NCT02919670
A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®) in Patients Receiving High-Dose Melphalan Conditioning Followed by Autologous Stem Cell Transplantation for Multiple Myeloma and Non-Hodgkin Lymphoma
Phase: N/A
Role: Collaborator
Start: Oct 31, 2016
Completion: Jul 31, 2020